Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Kalehua Capital Management LLC
Form 13F · Q2 2026

Kalehua Capital Management LLC

CIK 2106181申报日 2026-08-1913F-HR/A 在 EDGAR 查看原始申报 ↗
$1.7亿
申报组合市值
26
持仓数量
3
Quarters on record
Top 50
持仓数量

Kalehua Capital Management LLC——持仓

共 26 个持仓中的前 26 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1EA SERIES TRUST Ea Series Trust226,188+3.6%$2648万15.2%
2MANE Veradermics Inc145,695+0.0%$1791万10.3%
3XFOR X4 Pharmaceuticals Inc3.7M+0.0%$1739万10.0%
4CMPS Compass Pathways Plc819,692+0.0%$1160万6.7%
5SRZN Surrozen Inc385,178+0.0%$1000万5.7%
6ACRS Aclaris Therapeutics Inc1.8M+0.0%$969万5.6%
7SION Sionna Therapeutics Inc197,072+0.0%$867万5.0%
8IKT Inhibikase Therapeutics Inc3.8M+0.0%$776万4.5%
9PHVS Pharvaris N V198,772+0.0%$687万4.0%
10KPTIQ Karyopharm Therapeutics Inc685,644—$670万3.9%
11SEPN Septerna Inc194,544+0.0%$652万3.7%
12IFRX Inflarx Nv2.9M—$649万3.7%
13Cyclerion Therapeutics Inc Cyclerion Therapeutics Inc1.7M—$560万3.2%
14KRRO Korro Bio Inc405,040+270.3%$534万3.1%
15QURE Uniqure Nv79,407−72.7%$366万2.1%
16LONA Leonabio Inc393,701+0.0%$362万2.1%
17DMRA Damora Therapeutics Inc139,000+0.0%$362万2.1%
18MLTX Moonlake Immunotherapeutics175,734+0.0%$342万2.0%
19ANL Adlai Nortye Ltd226,415—$260万1.5%
20TYRA Tyra Biosciences Inc74,465+0.0%$238万1.4%
21NVCT Nuvectis Pharma Inc100,000—$184万1.1%
22GOSS Gossamer Bio Inc11.1M+8.9%$184万1.1%
23MIST Milestone Pharmaceuticals In1.3M—$170万1.0%
24ATYR Atyr Pharma Inc1.8M—$107万0.6%
25TIL Instil Bio Inc99,600−45.6%$77万0.4%
26TCRX Tscan Therapeutics Inc454,876—$45万0.3%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。